-
1
-
-
33644876621
-
Apolipoprotein B versus non-high-density lipoprotein cholesterol: And the winner is
-
DOI 10.1161/CIRCULATIONAHA.105.583336, PII 0000301720051129000002
-
Sniderman AD. Apolipoprotein B versus nonhigh-density lipoprotein cholesterol: and the winner is. Circulation 2005;112:3366-3367 (Pubitemid 43739547)
-
(2005)
Circulation
, vol.112
, Issue.22
, pp. 3366-3367
-
-
Sniderman, A.D.1
-
2
-
-
35148815698
-
Apolipoproteins A-I and B: Biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease
-
Olofsson SO, Wiklund O, Boren J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 2007;3:491-502 (Pubitemid 47542610)
-
(2007)
Vascular Health and Risk Management
, vol.3
, Issue.4
, pp. 491-502
-
-
Olofsson, S.-O.1
Wiklund, O.2
Boren, J.3
-
3
-
-
50649115698
-
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
-
Holme I, Cater NB, Faergeman O, et al. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL). Ann Med 2008;1-9
-
(2008)
Ann Med
, pp. 1-9
-
-
Holme, I.1
Cater, N.B.2
Faergeman, O.3
-
4
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
DOI 10.1056/NEJMoa050461
-
LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435 (Pubitemid 40471450)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.14
, pp. 1425-1435
-
-
Larosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.-C.6
Gotto, A.M.7
Greten, H.8
Kastelein, J.J.P.9
Shepherd, J.10
Wenger, N.K.11
-
5
-
-
27744603499
-
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: a randomized controlled trial
-
DOI 10.1001/jama.294.19.2437
-
Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005;294:2437-2445 (Pubitemid 41627921)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.19
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.P.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
Larsen, M.L.7
Bendiksen, F.S.8
Lindahl, C.9
Szarek, M.10
Tsai, J.11
-
6
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
DOI 10.1161/01.CIR.0000133317.49796.0E
-
Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239 (Pubitemid 38924592)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Bairey Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
7
-
-
0037126526
-
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
-
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
8
-
-
33646829645
-
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials
-
DOI 10.1136/bmj.38793.468449.AE
-
Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ 2006;332:1115-1124 (Pubitemid 44480873)
-
(2006)
British Medical Journal
, vol.332
, Issue.7550
, pp. 1115-1118
-
-
Costa, J.1
Borges, M.2
David, C.3
Vaz Carneiro, A.4
-
9
-
-
0017133795
-
Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver
-
Hamilton RL, Williams MC, Fielding CJ, Havel RJ. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 1976;58:667-680
-
(1976)
J Clin Invest
, vol.58
, pp. 667-680
-
-
Hamilton, R.L.1
Williams, M.C.2
Fielding, C.J.3
Havel, R.J.4
-
10
-
-
60549091035
-
High-density lipoproteins, inflammation and oxidative stress
-
Lond
-
Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009;116:87-98
-
(2009)
Clin Sci
, vol.116
, pp. 87-98
-
-
Tabet, F.1
Rye, K.A.2
-
11
-
-
33646409606
-
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- And ABCG1-dependent pathway
-
Matsuura F, Wang N, Chen W, et al. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 2006;116:1435-1442
-
(2006)
J Clin Invest
, vol.116
, pp. 1435-1442
-
-
Matsuura, F.1
Wang, N.2
Chen, W.3
-
12
-
-
0024449985
-
High-density lipoprotein - The clinical implications of recent studies
-
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15 (Pubitemid 19267219)
-
(1989)
New England Journal of Medicine
, vol.321
, Issue.19
, pp. 1311-1316
-
-
Gordon, D.J.1
Rifkind, B.M.2
-
13
-
-
11844296800
-
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: A meta-analysis of randomized controlled trials
-
DOI 10.1016/j.jacc.2004.10.031, PII S0735109704020625
-
Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005;45:185-197 (Pubitemid 40094724)
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.2
, pp. 185-197
-
-
Birjmohun, R.S.1
Hutten, B.A.2
Kastelein, J.J.P.3
Stroes, E.S.G.4
-
15
-
-
34447328718
-
Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study
-
DOI 10.1016/j.jacl.2007.05.003, PII S1933287407001407
-
Vittone F, Chait A, Morse JS, et al. Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: a Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). J Clin Lipidol 2007;1:203-210 (Pubitemid 47055291)
-
(2007)
Journal of Clinical Lipidology
, vol.1
, Issue.3
, pp. 203-210
-
-
Vittone, F.1
Chait, A.2
Morse, J.S.3
Fish, B.4
Brown, B.G.5
Zhao, X.-Q.6
-
16
-
-
10044281651
-
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
-
Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-3517
-
(2004)
Circulation
, vol.110
, pp. 3512-3517
-
-
Taylor, A.J.1
Sullenberger, L.E.2
Lee, H.J.3
-
17
-
-
40649089928
-
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: Magnetic resonance imaging study in an experimental model of atherosclerosis
-
Ibanez B, Vilahur G, Cimmino G, et al. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 2008;51:1104-1109
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1104-1109
-
-
Ibanez, B.1
Vilahur, G.2
Cimmino, G.3
-
18
-
-
0037124010
-
Milano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks
-
DOI 10.1161/01.RES.0000018422.31717.EE
-
Chiesa G, Monteggia E, Marchesi M, et al. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 2002;90:974-980 (Pubitemid 34633863)
-
(2002)
Circulation Research
, vol.90
, Issue.9
, pp. 974-980
-
-
Chiesa, G.1
Monteggia, E.2
Marchesi, M.3
Lorenzon, P.4
Laucello, M.5
Lorusso, V.6
Di Mario, C.7
Karvouni, E.8
Newton, R.S.9
Bisgaier, C.L.10
Franceschini, G.11
Sirtori, C.R.12
-
19
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
DOI 10.1056/NEJMoa0706628
-
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122 (Pubitemid 350146106)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.21
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
Grundy, S.M.4
Kastelein, J.J.P.5
Komajda, M.6
Lopez-Sendon, J.7
Mosca, L.8
Tardif, J.-C.9
Waters, D.D.10
Shear, C.L.11
Revkin, J.H.12
Buhr, K.A.13
Fisher, M.R.14
Tall, A.R.15
Brewer, B.16
-
20
-
-
35548955508
-
The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials
-
DOI 10.1016/j.ahj.2007.07.011, PII S0002870307005923
-
Saha SA, Kizhakepunnur LG, Bahekar A, Arora RR. The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials. Am Heart J 2007;154:943-953 (Pubitemid 350001283)
-
(2007)
American Heart Journal
, vol.154
, Issue.5
, pp. 943-953
-
-
Saha, S.A.1
Kizhakepunnur, L.G.2
Bahekar, A.3
Arora, R.R.4
-
21
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
-
22
-
-
63049137529
-
Long-acting calcium antagonists in patients with coronary artery disease: A meta-analysis
-
Bangalore S, Parkar S, Messerli FH. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis. Am J Med 2009;122:356-365
-
(2009)
Am J Med
, vol.122
, pp. 356-365
-
-
Bangalore, S.1
Parkar, S.2
Messerli, F.H.3
-
23
-
-
34447260981
-
β-blockers and progression of coronary atherosclerosis: Pooled analysis of 4 intravascular ultrasonography trials
-
Sipahi I, Tuzcu EM, Wolski KE, et al. Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 2007;147:10-18 (Pubitemid 351664629)
-
(2007)
Annals of Internal Medicine
, vol.147
, Issue.1
, pp. 10-18
-
-
Sipahi, I.1
Tuzcu, E.M.2
Wolski, K.E.3
Nicholls, S.J.4
Schoenhagen, P.5
Hu, B.6
Balog, C.7
Shishehbor, M.8
Magyar, W.A.9
Crowe, T.D.10
Kapadia, S.11
Nissen, S.E.12
-
24
-
-
0033104911
-
2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: Use of a novel inhibitor
-
MacPhee CH, Moores KE, Boyd HF, et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J 1999;338(Pt 2):479-487 (Pubitemid 129512274)
-
(1999)
Biochemical Journal
, vol.338
, Issue.1-2
, pp. 479-487
-
-
Macphee, C.H.1
Moores, K.E.2
Boyd, H.F.3
Dhanak, D.4
Ife, R.J.5
Leach, C.A.6
Leake, D.S.7
Milliner, K.J.8
Patterson, R.A.9
Suckling, K.E.10
Tew, D.G.11
Hickey, D.M.B.12
-
25
-
-
54049152760
-
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
-
Serruys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118:1172-1182
-
(2008)
Circulation
, vol.118
, pp. 1172-1182
-
-
Serruys, P.W.1
Garcia-Garcia, H.M.2
Buszman, P.3
-
26
-
-
53549093853
-
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
-
Wilensky RL, Shi Y, Mohler ER 3rd, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008;14:1059-1066
-
(2008)
Nat Med
, vol.14
, pp. 1059-1066
-
-
Wilensky, R.L.1
Shi, Y.2
Mohler III, E.R.3
-
27
-
-
0042510743
-
Inflammatory reactions in the pathogenesis of atherosclerosis
-
Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003;10:63-71
-
(2003)
J Atheroscler Thromb
, vol.10
, pp. 63-71
-
-
Fan, J.1
Watanabe, T.2
-
28
-
-
56549103855
-
Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: Questions and quandaries
-
Shiomi M, Fan J. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries. Curr Opin Lipidol 2008;19:631-636
-
(2008)
Curr Opin Lipidol
, vol.19
, pp. 631-636
-
-
Shiomi, M.1
Fan, J.2
-
29
-
-
42149117738
-
Progression and disruption of advanced atherosclerotic plaques in murine models
-
DOI 10.2174/138945008783755575
-
Rosenfeld ME, Averill MM, Bennett BJ, Schwartz SM. Progression and disruption of advanced atherosclerotic plaques in murine models. Curr Drug Targets 2008;9:210-216 (Pubitemid 351843602)
-
(2008)
Current Drug Targets
, vol.9
, Issue.3
, pp. 210-216
-
-
Rosenfeld, M.E.1
Averill, M.M.2
Bennett, B.J.3
Schwartz, S.M.4
-
30
-
-
0035480816
-
Lipoproteins and atherosclerosis in children: An early marriage?
-
Strong JP, Zieske AW, Malcom GT. Lipoproteins and atherosclerosis in children: an early marriage? Nutr Metab Cardiovasc Dis 2001;11(Suppl 5):16-22
-
(2001)
Nutr Metab Cardiovasc Dis
, vol.11
, Issue.SUPPL. 5
, pp. 16-22
-
-
Strong, J.P.1
Zieske, A.W.2
Malcom, G.T.3
-
31
-
-
0029151086
-
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
-
Original paper describing Stary classification for human atherosclerotic lesions
-
Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-1531 • Original paper describing Stary classification for human atherosclerotic lesions.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1512-1531
-
-
Stary, H.C.1
Chandler, A.B.2
Dinsmore, R.E.3
-
32
-
-
0028208606
-
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
-
This work describes the definition of early and intermediate atherosclerotic human lesions
-
Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840-856 • This work describes the definition of early and intermediate atherosclerotic human lesions.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 840-856
-
-
Stary, H.C.1
Chandler, A.B.2
Glagov, S.3
-
33
-
-
0019838940
-
A dissecting view on the role of the fatty streak in the pathogenesis of human atherosclerosis: Culprit or bystander?
-
Modified classification of human atherosclerosis as the cause for coronary thrombosis described by our laboratory. Herein we describe erosion and nodular calcification as addition causes for thrombosis. We also define the assumed precursor lesion to plaque rupture, vulnerable plaque
-
Velican C. A dissecting view on the role of the fatty streak in the pathogenesis of human atherosclerosis: culprit or bystander? Med Intern 1981;19:321-337 • Modified classification of human atherosclerosis as the cause for coronary thrombosis described by our laboratory. Herein we describe erosion and nodular calcification as addition causes for thrombosis. We also define the assumed precursor lesion to plaque rupture, vulnerable plaque.
-
(1981)
Med Intern
, vol.19
, pp. 321-337
-
-
Velican, C.1
-
34
-
-
0034019601
-
Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
-
Editorial describing the role of pathological intimal thickening in coronary plaque progression
-
Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275 •• Editorial describing the role of pathological intimal thickening in coronary plaque progression.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1262-1275
-
-
Virmani, R.1
Kolodgie, F.D.2
Burke, A.P.3
-
35
-
-
34247356508
-
Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease?
-
Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 2007;27:986-989
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 986-989
-
-
Kolodgie, F.D.1
Burke, A.P.2
Nakazawa, G.3
Virmani, R.4
-
36
-
-
0034958955
-
Pathophysiology of calcium deposition in coronary arteries
-
Burke AP, Weber DK, Kolodgie FD, et al. Pathophysiology of calcium deposition in coronary arteries. Herz 2001;26:239-244 (Pubitemid 32612691)
-
(2001)
Herz
, vol.26
, Issue.4
, pp. 239-244
-
-
Burke, A.P.1
Weber, D.K.2
Kolodgie, F.D.3
Farb, A.4
Taylor, A.J.5
Virmani, R.6
-
37
-
-
10344247664
-
Pathologic assessment of the vulnerable human coronary plaque
-
DOI 10.1136/hrt.2004.041798
-
Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart 2004;90:1385-1391 (Pubitemid 39626306)
-
(2004)
Heart
, vol.90
, Issue.12
, pp. 1385-1391
-
-
Kolodgie, F.D.1
Virmani, R.2
Burke, A.P.3
Farb, A.4
Weber, D.K.5
Kutys, R.6
Finn, A.V.7
Gold, H.K.8
-
38
-
-
0029876139
-
Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death
-
This paper compares the incidence and morphological characteristics of coronary thrombosis associated with plaque rupture versus thrombosis in eroded plaques without rupture at autopsy
-
Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363 •• This paper compares the incidence and morphological characteristics of coronary thrombosis associated with plaque rupture versus thrombosis in eroded plaques without rupture at autopsy.
-
(1996)
Circulation
, vol.93
, pp. 1354-1363
-
-
Farb, A.1
Burke, A.P.2
Tang, A.L.3
-
39
-
-
0003132710
-
Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization
-
PII S0002934398000412
-
Libby P, Schoenbeck U, Mach F, et al. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:14S-18S (Pubitemid 28166572)
-
(1998)
American Journal of Medicine
, vol.104
, Issue.2 A
-
-
Libby, P.1
Schoenbeck, U.2
Mach, F.3
Selwyn, A.P.4
Ganz, P.5
-
40
-
-
0030961921
-
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
-
Autopsy analysis of the effects of cigarette smoking and abnormal cholesterol values on coronary plaque morphology in men with coronary disease and sudden death
-
Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282 •• Autopsy analysis of the effects of cigarette smoking and abnormal cholesterol values on coronary plaque morphology in men with coronary disease and sudden death.
-
(1997)
N Engl J Med
, vol.336
, pp. 1276-1282
-
-
Burke, A.P.1
Farb, A.2
Malcom, G.T.3
-
41
-
-
26244463577
-
Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage
-
DOI 10.1161/01.ATV.0000178991.71605.18
-
Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061 (Pubitemid 41416300)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.10
, pp. 2054-2061
-
-
Virmani, R.1
Kolodgie, F.D.2
Burke, A.P.3
Finn, A.V.4
Gold, H.K.5
Tulenko, T.N.6
Wrenn, S.P.7
Narula, J.8
-
42
-
-
0022389171
-
Cholesterol and the cell membrane
-
Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985;822:267-287
-
(1985)
Biochim Biophys Acta
, vol.822
, pp. 267-287
-
-
Yeagle, P.L.1
-
43
-
-
0031899062
-
Physical effects of cholesterol on arterial smooth muscle membranes: Evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis
-
Tulenko TN, Chen M, Mason PE, Mason RP. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J Lipid Res 1998;39:947-956 (Pubitemid 28221998)
-
(1998)
Journal of Lipid Research
, vol.39
, Issue.5
, pp. 947-956
-
-
Tulenko, T.N.1
Chen, M.2
Mason, P.E.3
Mason, R.P.4
-
44
-
-
0344235454
-
Intraplaque hemorrhage and progression of coronary atheroma
-
This paper examines the role of intraplaque hemorrhage in coronary plaque progression in a large series of patients with sudden coronary death
-
Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325 •• This paper examines the role of intraplaque hemorrhage in coronary plaque progression in a large series of patients with sudden coronary death.
-
(2003)
N Engl J Med
, vol.349
, pp. 2316-2325
-
-
Kolodgie, F.D.1
Gold, H.K.2
Burke, A.P.3
-
45
-
-
34248639027
-
Elimination of neoangiogenesis for plaque stabilization: Is there a role for local drug therapy?
-
Kolodgie FD, Narula J, Yuan C, et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol 2007;49:2093-2101
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2093-2101
-
-
Kolodgie, F.D.1
Narula, J.2
Yuan, C.3
-
46
-
-
11144227415
-
ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages
-
DOI 10.1161/01.ATV.0000148323.94021.e5
-
Dove DE, Su YR, Zhang W, et al. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Arterioscler Thromb Vasc Biol 2005;25:128-134 (Pubitemid 40054265)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.1
, pp. 128-134
-
-
Dove, D.E.1
Su, Y.R.2
Zhang, W.3
Jerome, W.G.4
Swift, L.L.5
Linton, M.F.6
Fazio, S.7
-
47
-
-
0032800248
-
Crystallization of free cholesterol in model macrophage foam cells
-
Kellner-Weibel G, Yancey PG, Jerome WG, et al. Crystallization of free cholesterol in model macrophage foam cells. Arterioscler Thromb Vasc Biol 1999;19:1891-1898 (Pubitemid 29379918)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.8
, pp. 1891-1898
-
-
Kellner-Weibel, G.1
Yancey, P.G.2
Jerome, W.G.3
Walser, T.4
Mason, R.P.5
Phillips, M.C.6
Rothblat, G.H.7
-
48
-
-
27644537437
-
Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency
-
Review of the role and mechanisms of macrophage apoptosis in atherosclerosis
-
Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 2005;25:2255-2264 • Review of the role and mechanisms of macrophage apoptosis in atherosclerosis.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2255-2264
-
-
Tabas, I.1
-
49
-
-
0030857552
-
Relation of plaque lipid composition and morphology to the stability of human aortic plaques
-
Felton CV, Crook D, Davies MJ, Oliver MF. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 1997;17:1337-1345 (Pubitemid 27329858)
-
(1997)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.17
, Issue.7
, pp. 1337-1345
-
-
Felton, C.V.1
Crook, D.2
Davies, M.J.3
Oliver, M.F.4
-
50
-
-
0032842812
-
Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption
-
Autopsy analysis demonstrating the role of subclinical plaque disruption and healing in plaque growth
-
Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265-268 • Autopsy analysis demonstrating the role of subclinical plaque disruption and healing in plaque growth.
-
(1999)
Heart
, vol.82
, pp. 265-268
-
-
Mann, J.1
Davies, M.J.2
-
51
-
-
0035916310
-
Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression
-
Autopsy analysis examining the role of silent plaque rupture and healing as a cause of progressive luminal stenosis
-
Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940 • Autopsy analysis examining the role of silent plaque rupture and healing as a cause of progressive luminal stenosis.
-
(2001)
Circulation
-
-
Burke, A.P.1
Kolodgie, F.D.2
Farb, A.3
-
52
-
-
0037926586
-
34th Bethesda Conference: Task force #2-what is the pathologic basis for new atherosclerosis imaging techniques?
-
Review of the most important pathologic feature of vulnerable plaque that might be amenable to imaging
-
Burke AP, Virmani R, Galis Z, et al. 34th Bethesda Conference: task force #2-what is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol 2003;41:1874-1886 • Review of the most important pathologic feature of vulnerable plaque that might be amenable to imaging.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1874-1886
-
-
Burke, A.P.1
Virmani, R.2
Galis, Z.3
-
53
-
-
3042818389
-
Morphologic findings of coronary atherosclerotic plaques in diabetics: A postmortem study
-
DOI 10.1161/01.ATV.0000131783.74034.97
-
Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004;24:1266-1271 (Pubitemid 38880019)
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.7
, pp. 1266-1271
-
-
Burke, A.P.1
Kolodgie, F.D.2
Zieske, A.3
Fowler, D.R.4
Weber, D.K.5
Varghese, P.J.6
Farb, A.7
Virmani, R.8
-
54
-
-
0037015230
-
C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: The Framingham Heart Study
-
DOI 10.1161/01.CIR.0000032135.98011.C4
-
Wang TJ, Larson MG, Levy D, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002;106:1189-1191 (Pubitemid 34988633)
-
(2002)
Circulation
, vol.106
, Issue.10
, pp. 1189-1191
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
Benjamin, E.J.4
Kupka, M.J.5
Manning, W.J.6
Clouse, M.E.7
D'Agostino, R.B.8
Wilson, P.W.F.9
O'Donnell, C.J.10
-
56
-
-
0031937705
-
Animal models of atherosclerosis and interpretation of drug intervention studies
-
Bocan TM. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr Pharm Des 1998;4:37-52 (Pubitemid 28090067)
-
(1998)
Current Pharmaceutical Design
, vol.4
, Issue.1
, pp. 37-52
-
-
Bocan, T.M.A.1
-
57
-
-
0027396072
-
Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment
-
Kaplan JR, Manuck SB, Adams MR, et al. Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment. Arterioscler Thromb 1993;13:254-263 (Pubitemid 23056799)
-
(1993)
Arteriosclerosis and Thrombosis
, vol.13
, Issue.2
, pp. 254-263
-
-
Kaplan, J.R.1
Manuck, S.B.2
Adams, M.R.3
Williams, J.K.4
Register, T.C.5
Clarkson, T.B.6
-
58
-
-
0028853846
-
Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits
-
Shiomi M, Ito T, Tsukada T, et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995;15:1938-1944
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1938-1944
-
-
Shiomi, M.1
Ito, T.2
Tsukada, T.3
-
59
-
-
0032560637
-
Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
-
This paper demonstrates that lipid lowering by diet in the rabbit atheroscerlotic model reduces expression of enzymes that degrade extracellular matrix and thereby stabilizes plaques
-
Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998;97:2433-2444 • This paper demonstrates that lipid lowering by diet in the rabbit atheroscerlotic model reduces expression of enzymes that degrade extracellular matrix and thereby stabilizes plaques.
-
(1998)
Circulation
, vol.97
, pp. 2433-2444
-
-
Aikawa, M.1
Rabkin, E.2
Okada, Y.3
-
60
-
-
0035916305
-
Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits
-
Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001;103:993-999 (Pubitemid 32183806)
-
(2001)
Circulation
, vol.103
, Issue.7
, pp. 993-999
-
-
Fukumoto, Y.1
Libby, P.2
Rabkin, E.3
Hill, C.C.4
Enomoto, M.5
Hirouchi, Y.6
Shiomi, M.7
Aikawa, M.8
-
61
-
-
0032538870
-
Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma
-
Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998;83:1015-1026 (Pubitemid 28520931)
-
(1998)
Circulation Research
, vol.83
, Issue.10
, pp. 1015-1026
-
-
Aikawa, M.1
Rabkin, E.2
Voglic, S.J.3
Shing, H.4
Nagai, R.5
Schoen, F.J.6
Libby, P.7
-
62
-
-
0033554455
-
Dietary lipid lowering reduces tissue factor expression in rabbit atheroma
-
Aikawa M, Voglic SJ, Sugiyama S, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation 1999;100:1215-1222 (Pubitemid 29426598)
-
(1999)
Circulation
, vol.100
, Issue.11
, pp. 1215-1222
-
-
Aikawa, M.1
Voglic, S.J.2
Sugiyama, S.3
Rabkin, E.4
Taubman, M.B.5
Fallon, J.T.6
Libby, P.7
-
64
-
-
0027976942
-
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
-
Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994;14:141-147
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 141-147
-
-
Reddick, R.L.1
Zhang, S.H.2
Maeda, N.3
-
65
-
-
0034807277
-
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice
-
DOI 10.1002/path.915
-
Calara F, Silvestre M, Casanada F, et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 2001;195:257-263 (Pubitemid 32899037)
-
(2001)
Journal of Pathology
, vol.195
, Issue.2
, pp. 257-263
-
-
Calara, F.1
Silvestre, M.2
Casanada, F.3
Yuan, N.4
Napoli, C.5
Palinski, W.6
-
66
-
-
0035162266
-
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
-
Sparrow CP, Burton CA, Hernandez M, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:115-121 (Pubitemid 32061935)
-
(2001)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.21
, Issue.1
, pp. 115-121
-
-
Sparrow, C.P.1
Burton, C.A.2
Hernandez, M.3
Mundt, S.4
Hassing, H.5
Patel, S.6
Rosa, R.7
Hermanowski-Vosatka, A.8
Wang, P.-R.9
Zhang, D.10
Peterson, L.11
Detmers, P.A.12
Chao, Y.-S.13
Wright, S.D.14
-
67
-
-
34147152963
-
Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice
-
DOI 10.1016/j.phrs.2007.02.001, PII S1043661807000448
-
Monetti M, Canavesi M, Camera M, et al. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacol Res 2007;55:441-449 (Pubitemid 46560397)
-
(2007)
Pharmacological Research
, vol.55
, Issue.5
, pp. 441-449
-
-
Monetti, M.1
Canavesi, M.2
Camera, M.3
Parente, R.4
Paoletti, R.5
Tremoli, E.6
Corsini, A.7
Bellosta, S.8
-
68
-
-
33644627717
-
-/- mouse model of atherosclerosis
-
DOI 10.1016/j.lfs.2005.08.041, PII S0024320505010519
-
Nachtigal P, Pospisilova N, Pospechova K, et al. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis. Life Sci 2006;78:1983-1989 (Pubitemid 43319578)
-
(2006)
Life Sciences
, vol.78
, Issue.17
, pp. 1983-1989
-
-
Nachtigal, P.1
Pospisilova, N.2
Pospechova, K.3
Jamborova, G.4
Kopecky, M.5
Jaynes, R.6
Briestensky, J.7
Santar, I.8
Smahelova, A.9
Solichova, D.10
Zdansky, P.11
Semecky, V.12
-
69
-
-
0031445149
-
Attenuation of plasma low density lipoprotein cholesterol by select 3- Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in mice devoid of low density lipoprotein receptors
-
Bisgaier CL, Essenburg AD, Auerbach BJ, et al. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. J Lipid Res 1997;38:2502-2515 (Pubitemid 28028135)
-
(1997)
Journal of Lipid Research
, vol.38
, Issue.12
, pp. 2502-2515
-
-
Bisgaier, C.L.1
Essenburg, A.D.2
Auerbach, B.J.3
Pape, M.E.4
Sekerke, C.S.5
Gee, A.6
Wolle, S.7
Newton, R.S.8
-
70
-
-
0036223846
-
Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein e
-
DOI 10.1016/S0021-9150(01)00678-5, PII S0021915001006785
-
Wang YX, Martin-McNulty B, Huw LY, et al. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. Atherosclerosis 2002;162:23-31 (Pubitemid 34327338)
-
(2002)
Atherosclerosis
, vol.162
, Issue.1
, pp. 23-31
-
-
Wang, Y.-X.1
Martin-McNulty, B.2
Huw, L.-Y.3
Da Cunha, V.4
Post, J.5
Hinchman, J.6
Vergona, R.7
Sullivan, M.E.8
Dole, W.9
Kauser, K.10
-
71
-
-
0036645435
-
Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids
-
DOI 10.1161/01.CIR.0000022843.76104.01
-
Chen Z, Fukutomi T, Zago AC, et al. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 2002;106:20-23 (Pubitemid 34747436)
-
(2002)
Circulation
, vol.106
, Issue.1
, pp. 20-23
-
-
Chen, Z.1
Fukutomi, T.2
Zago, A.C.3
Ehlers, R.4
Detmers, P.A.5
Wright, S.D.6
Rogers, C.7
Simon, D.I.8
-
72
-
-
0028268018
-
The two-receptor model of lipoprotein clearance: Tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
-
Ishibashi S, Herz J, Maeda N, et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994;91:4431-4435
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 4431-4435
-
-
Ishibashi, S.1
Herz, J.2
Maeda, N.3
-
73
-
-
40649124979
-
Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice
-
Nachtigal P, Pospisilova N, Jamborova G, et al. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Life Sci 2008;82:708-717
-
(2008)
Life Sci
, vol.82
, pp. 708-717
-
-
Nachtigal, P.1
Pospisilova, N.2
Jamborova, G.3
-
74
-
-
0028215636
-
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice
-
van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, et al. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994;93:1403-1410 (Pubitemid 24116375)
-
(1994)
Journal of Clinical Investigation
, vol.93
, Issue.4
, pp. 1403-1410
-
-
Van Vlijmen, B.J.M.1
Van Den Maagdenberg, A.M.J.M.2
Gijbels, M.J.J.3
Van Der Boom, H.4
Hogenesch, H.5
Frants, R.R.6
Hofker, M.H.7
Havekes, L.M.8
-
75
-
-
0033015655
-
Role of apoCs in lipoprotein metabolism: Functional differences between ApoC1, ApoC2, and ApoC3
-
Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999;19:472-484 (Pubitemid 29135144)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.3
, pp. 472-484
-
-
Jong, M.C.1
Hofker, M.H.2
Havekes, L.M.3
-
76
-
-
34547624651
-
Mouse models for atherosclerosis and pharmaceutical modifiers
-
Review of mouse models of atherosclerosis and the effect of different pharmacologic agents for
-
Zadelaar S, Kleemann R, Verschuren L, et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007;27:1706-1721 • Review of mouse models of atherosclerosis and the effect of different pharmacologic agents for
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1706-1721
-
-
Zadelaar, S.1
Kleemann, R.2
Verschuren, L.3
-
77
-
-
2542465868
-
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
-
DOI 10.1182/blood-2003-11-3791
-
Kleemann R, Verschuren L, de Rooij BJ, et al. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 2004;103:4188-4194 (Pubitemid 38685361)
-
(2004)
Blood
, vol.103
, Issue.11
, pp. 4188-4194
-
-
Kleemann, R.1
Verschuren, L.2
De Rooij, B.-J.3
Lindeman, J.4
De Maat, M.M.5
Szalai, A.J.6
Princen, H.M.G.7
Kooistra, T.8
-
78
-
-
39749145196
-
Translating molecular discoveries into new therapies for atherosclerosis
-
Review discussing how to translate molecular insights into atherosclerosis into new therapies
-
Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008;451:904-913 • Review discussing how to translate molecular insights into atherosclerosis into new therapies.
-
(2008)
Nature
, vol.451
, pp. 904-913
-
-
Rader, D.J.1
Daugherty, A.2
-
79
-
-
0031138861
-
The composition of coronary-artery plaques
-
Davies MJ. The composition of coronary-artery plaques. N Engl J Med 1997;336:1312-1314
-
(1997)
N Engl J Med
, vol.336
, pp. 1312-1314
-
-
Davies, M.J.1
-
80
-
-
0029090411
-
Coronary plaque disruption
-
Review of the role of coronary plaque disruption on atherosclerosis
-
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671 •• Review of the role of coronary plaque disruption on atherosclerosis.
-
(1995)
Circulation
, vol.92
, pp. 657-671
-
-
Falk, E.1
Shah, P.K.2
Fuster, V.3
-
81
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
DOI 10.1016/S0140-6736(02)11600-X
-
Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-1630 (Pubitemid 35379733)
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.E.M.4
Buckley, B.M.5
Cobbe, S.M.6
Ford, I.7
Gaw, A.8
Hyland, M.9
Jukema, J.W.10
Kamper, A.M.11
Macfarlane, P.W.12
Meinders, A.E.13
Norrie, J.14
Packard, C.J.15
Perry, I.J.16
Stott, D.J.17
Sweeney, B.J.18
Twomey, C.19
Westendorp, R.G.J.20
more..
-
82
-
-
0037420492
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
-
DOI 10.1016/S0140-6736(03)12948-0
-
Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158 (Pubitemid 36398384)
-
(2003)
Lancet
, vol.361
, Issue.9364
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlof, B.2
Poulter, N.R.3
Wedel, H.4
Beevers, G.5
Caulfield, M.6
Collins, R.7
Kjeldsen, S.E.8
Kristinsson, A.9
McInnes, G.T.10
Mehlsen, J.11
Nieminen, M.12
O'Brien, E.13
Ostergren, J.14
-
83
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504 (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
84
-
-
0037132607
-
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
-
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007
-
(2002)
JAMA
, vol.288
, pp. 2998-3007
-
-
-
85
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
-
DOI 10.1016/S0140-6736(02)09327-3
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22 (Pubitemid 34756487)
-
(2002)
Lancet
, vol.360
, Issue.9326
, pp. 7-22
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleight, P.4
Peto, R.5
-
86
-
-
33744960230
-
Effect of ACAT inhibition on the progression of coronary atherosclerosis: A randomized controlled trial
-
Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-1565 (Pubitemid 43853488)
-
(2006)
ACC Cardiosource Review Journal
, vol.15
, Issue.5
, pp. 95-96
-
-
Nissen, S.E.1
Michelson, E.L.2
-
87
-
-
10744225301
-
Effect of Intensive Compared with Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial
-
DOI 10.1001/jama.291.9.1071
-
Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080 (Pubitemid 38541684)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.9
, pp. 1071-1080
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Schoenhagen, P.3
Brown, B.G.4
Ganz, P.5
Vogel, R.A.6
Crowe, T.7
Howard, G.8
Cooper, C.J.9
Brodie, B.10
Grines, C.L.11
Demaria, A.N.12
-
88
-
-
0037081721
-
Impact of nonmeasurable borders and variation in cross-section counts on intravascular ultrasound measurement of atherosclerotic plaque volume
-
DOI 10.1016/S0002-9149(01)02195-6, PII S0002914901021956
-
Casserly IP, Ziada K, Kapadia S, et al. Impact of nonmeasurable borders and variation in cross-section counts on intravascular ultrasound measurement of atherosclerotic plaque volume. Am J Cardiol 2002;89:169-173 (Pubitemid 34132905)
-
(2002)
American Journal of Cardiology
, vol.89
, Issue.2
, pp. 169-173
-
-
Casserly, I.P.1
Ziada, K.2
Kapadia, S.3
Schoenhagen, P.4
Tsutsui, H.5
Karafa, M.6
Shah, A.7
Popovich, J.8
Nissen, S.E.9
Tuzcu, E.M.10
-
89
-
-
39249083201
-
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial
-
Underhill HR, Yuan C, Zhao XQ, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008;155:584 e1-8
-
(2008)
Am Heart J
, vol.155
-
-
Underhill, H.R.1
Yuan, C.2
Zhao, X.Q.3
-
90
-
-
0025121280
-
Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest
-
DOI 10.1016/0002-9149(90)90482-G
-
Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 1990;66:562-567 (Pubitemid 20292512)
-
(1990)
American Journal of Cardiology
, vol.66
, Issue.5
, pp. 562-567
-
-
Kragel, A.H.1
Reddy, S.G.2
Wittes, J.T.3
Roberts, W.C.4
-
91
-
-
33750223516
-
Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
-
DOI 10.1161/01.ATV.0000244681.72738.bc, PII 0004360520061100000017
-
Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:2523-2529 (Pubitemid 44607475)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.11
, pp. 2523-2529
-
-
Kolodgie, F.D.1
Burke, A.P.2
Skorija, K.S.3
Ladich, E.4
Kutys, R.5
Makuria, A.T.6
Virmani, R.7
-
92
-
-
0036305114
-
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: The ATROCAP Study
-
Cortellaro M, Cofrancesco E, Arbustini E, et al. Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study. Thromb Haemost 2002;88:41-47 (Pubitemid 34752265)
-
(2002)
Thrombosis and Haemostasis
, vol.88
, Issue.1
, pp. 41-47
-
-
Cortellaro, M.1
Confrancesco, E.2
Arbustini, E.3
Rossi, F.4
Negri, A.5
Tremoli, E.6
Gabrielli, L.7
Camera, M.8
-
93
-
-
33747161047
-
Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: A retrospective study in 378 patients undergoing carotid endarterectomy
-
DOI 10.1161/01.STR.0000231685.82795.e5, PII 0000767020060800000025
-
Verhoeven BA, Moll FL, Koekkoek JA, et al. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke 2006;37:2054-2060 (Pubitemid 44309903)
-
(2006)
Stroke
, vol.37
, Issue.8
, pp. 2054-2060
-
-
Verhoeven, B.A.N.1
Moll, F.L.2
Koekkoek, J.A.F.3
Van Der Wal, A.C.4
De Kleijn, D.P.V.5
De Vries, J.P.P.M.6
Verheijen, J.H.7
Velema, E.8
Busser, E.9
Schoneveld, A.10
Virmani, R.11
Pasterkamp, G.12
-
94
-
-
23244447710
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
-
DOI 10.1161/01.STR.0000174289.34110.b0
-
Martin-Ventura JL, Blanco-Colio LM, Gomez-Hernandez A, et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke 2005;36:1796-1800 (Pubitemid 41098781)
-
(2005)
Stroke
, vol.36
, Issue.8
, pp. 1796-1800
-
-
Martin-Ventura, J.L.1
Blanco-Colio, L.M.2
Gomez-Hernandez, A.3
Munoz-Garcia, B.4
Vega, M.5
Serrano, J.6
Ortega, L.7
Hernandez, G.8
Tunon, J.9
Egido, J.10
-
95
-
-
0035916233
-
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization
-
Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001;103:926-933 (Pubitemid 32183796)
-
(2001)
Circulation
, vol.103
, Issue.7
, pp. 926-933
-
-
Crisby, M.1
Nordin-Fredriksson, G.2
Shah, P.K.3
Yano, J.4
Zhu, J.5
Nilsson, J.6
-
96
-
-
58849102557
-
Carotid atherosclerotic plaques stabilize after stroke: Insights into the natural process of atherosclerotic plaque stabilization
-
This paper examines the pathophysiology of lesion stabilization after symptomatic stroke in a large series of carotid endarterectomies
-
Peeters W, Hellings WE, de Kleijn DP, et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009;29:128-133 •• This paper examines the pathophysiology of lesion stabilization after symptomatic stroke in a large series of carotid endarterectomies.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 128-133
-
-
Peeters, W.1
Hellings, W.E.2
De Kleijn, D.P.3
-
97
-
-
14844335659
-
Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients
-
Hsu HY, Wang PY, Chen YT, et al. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients. J Chin Med Assoc 2005;68:53-58 (Pubitemid 40347993)
-
(2005)
Journal of the Chinese Medical Association
, vol.68
, Issue.2
, pp. 53-58
-
-
Hsu, H.-Y.1
Wang, P.-Y.2
Chen, Y.-T.3
Sheu, W.H.-H.4
Hu, H.-H.5
Sheng, W.-Y.6
-
98
-
-
43949093109
-
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: The baseline findings of the MIAMI study
-
DOI 10.1016/j.numecd.2007.01.008, PII S0939475307000245
-
Porta B, Baldassarre D, Camera M, et al. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study. Nutr Metab Cardiovasc Dis 2008;18:320-328 (Pubitemid 351707612)
-
(2008)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.18
, Issue.4
, pp. 320-328
-
-
Porta, B.1
Baldassarre, D.2
Camera, M.3
Amato, M.4
Arquati, M.5
Brusoni, B.6
Fiorentini, C.7
Montorsi, P.8
Romano, S.9
Tremoli, E.10
Cortellaro, M.11
-
99
-
-
56249127895
-
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk
-
Forst T, Wilhelm B, Pfutzner A, et al. Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk. Diab Vasc Dis Res 2008;5:298-303
-
(2008)
Diab Vasc Dis Res
, vol.5
, pp. 298-303
-
-
Forst, T.1
Wilhelm, B.2
Pfutzner, A.3
-
100
-
-
34248231748
-
Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens
-
DOI 10.1016/j.atherosclerosis.2007.01.035, PII S0021915007000640
-
Koutouzis M, Nomikos A, Nikolidakis S, et al. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis 2007;192:457-463 (Pubitemid 46726342)
-
(2007)
Atherosclerosis
, vol.192
, Issue.2
, pp. 457-463
-
-
Koutouzis, M.1
Nomikos, A.2
Nikolidakis, S.3
Tzavara, V.4
Andrikopoulos, V.5
Nikolaou, N.6
Barbatis, C.7
Kyriakides, Z.S.8
-
101
-
-
61749103652
-
CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima
-
Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009;119:136-145
-
(2009)
J Clin Invest
, vol.119
, pp. 136-145
-
-
Park, Y.M.1
Febbraio, M.2
Silverstein, R.L.3
-
102
-
-
3042613500
-
Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively
-
DOI 10.1016/j.amjcard.2004.03.050, PII S0002914904004643
-
Molloy KJ, Thompson MM, Schwalbe EC, et al. Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol 2004;94:144-146 (Pubitemid 38813475)
-
(2004)
American Journal of Cardiology
, vol.94
, Issue.1
, pp. 144-146
-
-
Molloy, K.J.1
Thompson, M.M.2
Schwalbe, E.C.3
Bell, P.R.F.4
Naylor, A.R.5
Loftus, I.M.6
|